Developer docs
API playgroundTry for free, no card

Search company profiles

NutraResearch

Full company profile

uuid00272i6

Namestring
NutraResearch
Legal namestring
Nutraresearch 2011, S.L.
Company typeenum
Private
Founded yearint
2011
Descriptiontext

NutraResearch is a Barcelona-based pharmaceutical Contract Development and Manufacturing Organization (CDMO) that provides end-to-end research, development, and custom manufacturing services for dietary supplements, medical devices, and nutricosmetic products. Founded in 2011 in L'Hospitalet de Llobregat by pharmaceutical industry veterans Carlos Fernández and Carlos Stampa, the company serves pharmaceutical firms, food supplement brands, and cosmetics companies across Europe. Its service portfolio spans the full product lifecycle: active ingredient (API) selection, formulation development, analytical development, industrialization and technology transfer, regulatory dossier preparation, and industrial-scale manufacturing. The company operates a development center and pilot plant at its L'Hospitalet headquarters and a 24/7 three-shift production plant in Barberà del Vallès, the latter acquired in 2021 through the NutraProcés transaction that vertically integrated manufacturing into the platform.

The company's core technology differentiator is its Next-Generation Dietary Supplement Technology Platform, which adapts pharmaceutical-grade controlled-release engineering (including 8+ hour and colon-targeted release profiles) and mucosa bioadhesion chemistry to phytotherapeutic extracts — a class of natural actives whose variability has historically made modified release difficult. In October 2023, NutraResearch also launched the first 100% recyclable blister packaging free of vinyl and aluminum, with moisture barrier performance validated under ICH Q1A stability protocols. The company is a project-based, multi-year B2B enterprise with custom-quoted pricing; revenue is generated through contract R&D services, custom manufacturing (CDMO), and technology transfer. It is part of the Swedish Wellma Group following a January 2025 strategic integration, and participates in the EU-funded SUSTAINEXT consortium (21 companies, 54 months) targeting 40 new active ingredients from sustainable plant cultivation. In April 2025 it became the first food supplement company worldwide to obtain ISO 56001 Innovation Management certification.

Short descriptiontext

NutraResearch is a Barcelona-based pharmaceutical CDMO providing end-to-end R&D, formulation, regulatory, and custom manufacturing services for dietary supplements, medical devices, and nutricosmetics, serving pharmaceutical firms and supplement brands across Europe as part of the Wellma Group.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHospitalet De Llobregat, Spain
HQ citystring
Hospitalet De Llobregat
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical contract development, nutraceutical CDMO services, dietary supplement formulation, controlled release technology, custom manufacturing services
Industry2 codes
PRIMARYHLAGABAB
Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAJ
Packaging, Labeling & Serialization (Clinical/Commercial) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
NAICS code1 code
  • Pharmaceutical and Medicine Manufacturing3254
SIC code1 code
  • Medicinal Chemicals & Botanical Products2833
Product category
Contract Pharmaceutical and Nutraceutical Manufacturing
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Contract R&D Services
TypeProfessional Services
Description

Full-service research and development for pharmaceutical and nutraceutical products, including formulation development, analytical development, and registration dossier preparation. Services range from active substance selection through market-ready product development.

nutraresearch.es
2Custom Manufacturing (CDMO)
TypeOne Time License
Description

Contract manufacturing of dietary supplements, medical devices, and nutraceutical cosmetics at industrial scale. Following acquisition of Nutraprocés, NutraResearch operates both development pilot plant and production facilities.

nutraresearch.es
3Technology Transfer Services
TypeProfessional Services
Description

Transfer of manufacturing methods and processes to client facilities, enabling clients to produce products internally after development.

nutraresearch.es
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1Project-based pricing for R&D and manufacturing services
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing determined by project scope, formulation complexity, production volumes, regulatory requirements, and service bundle selections. No public pricing available as all engagements are custom quotes.

nutraresearch.es
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

NutraResearch is a Barcelona-based CDMO providing contract R&D, formulation development, analytical services, technology transfer, registration dossier preparation, and industrial-scale custom manufacturing for pharmaceutical and nutraceutical companies. The company applies pharmaceutical-grade technologies — including controlled-release platforms, bioadhesion, and sustainable blister packaging — to develop and manufacture next-generation food supplements, medical devices, and nutraceutical cosmetics.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • First food supplement company worldwide to achieve ISO 56001 certification (April 2025)
+3 more records
Product overview1 text field

NutraResearch is a leading Barcelona-based CDMO (Contract Development and Manufacturing Organization) specializing in research, development, technology transfer, and custom manufacturing of next-generation food supplements, medical devices, and nutraceutical cosmetics. The company operates as a unified service and product platform offering comprehensive R&D services (API selection, formulation development, analytical development, industrialization, tech transfer, and registration dossiers) alongside a portfolio of 14 dietary supplement product categories covering sports nutrition, skin care, hair care, joint health, weight control, cleansing, anti-stress, veterinary, gynecological, eye care, intestinal health, metabolism regulation, antioxidants, and sleep support. Key technological differentiators include a next-generation controlled-release tablet platform (adapted from pharmaceutical technology), bioadhesion technology for liquid supplements, and the first 100% recyclable sustainable blister packaging. The company, now part of the Swedish Wellma Group following a January 2025 acquisition, serves pharmaceutical and supplement firms across Europe.

Product and service13 records
1API Selection Service
CategoryContract R&D Services
Description

Expert fitotherapy and botany services for selecting active ingredients that form the basis for product effectiveness, provided to pharmaceutical and nutraceutical client companies.

2Formulation Development Service
CategoryContract R&D Services
Description

Pharmaceutical technology expertise to formulate active ingredients into effective and stable products with optimal release at the point of action, provided to pharmaceutical and supplement companies.

3Analytical Development Service
CategoryContract R&D Services
Description

Partner-provided analytical tools for conducting necessary analytical determinations for new product development, available to pharmaceutical and nutraceutical clients.

4Industrialization and Tech Transfer Service
CategoryContract Manufacturing Services
Description

Comprehensive industrialization services including custom manufacturing through Nutraprocés plant and tech transfer to client facilities for pharmaceutical and supplement brands.

5Registration Dossier Service
CategoryRegulatory Services
Description

Preparation with extensive in-house experience of registration dossiers for new products and modifications of registration dossiers for existing products, serving pharmaceutical and nutraceutical companies.

6Custom Manufacturing (CDMO)
CategoryContract Manufacturing Services
Description

Contract manufacturing of dietary supplements, medical devices, and nutraceutical cosmetics at industrial scale through the production plant in Barberà del Vallès, operating 24/7 in three shifts.

7Sport Nutrition Supplements
CategoryDietary Supplements
Description

Dietary supplements formulated for athletic performance, muscle recovery, and sports-related nutritional support.

8Skin Care Supplements
CategoryDietary Supplements
Description

Nutraceutical products targeting skin health and beauty from within, utilizing advanced formulation technologies.

9Capillary Care Products
CategoryDietary Supplements
Description

Dietary supplements formulated to support hair health, strength, and growth.

10Osteoarticular Supplements
CategoryDietary Supplements
Description

Supplements designed to support joint health, bone strength, and musculoskeletal system function.

11Weight Control Products
CategoryDietary Supplements
Description

Dietary supplements formulated to support weight management and metabolic health.

12Veterinary Products
CategoryVeterinary Supplements
Description

Nutraceutical formulations designed specifically for animal health applications.

13Sustainable Blister Packaging
CategoryPharmaceutical Packaging
Description

First 100% recyclable blister packaging free from vinyl and aluminum, providing moisture protection equivalent to 120-gram PVDC coating, validated through ICH Q1A stability studies.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-30
Description

Strategic partnership joining NutraResearch with Wellma, a leading European nutraceutical and pharmaceutical CDMO with €100M+ in sales. The partnership expands NutraResearch's access to broader product portfolio and greater R&D capabilities, while strengthening Wellma's pan-European presence. NutraResearch operates as part of Wellma's ecosystem while maintaining entrepreneurial culture. Christian Merup is CEO of Wellma.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

European consortium project (54 months duration) funded by Circular Bio-based Europe Joint Undertaking (CBE JU), bringing together 21 companies to cultivate medicinal plants for nutraceutical and biofuel applications. NutraResearch serves as expert in phytotherapy and galenic formulation, transforming plant extracts into dietary supplements. Project aims to replace tobacco cultivation in Extremadura with medicinal plants and achieve zero waste/zero emissions. Natac leads and coordinates the project.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Spanish company and leader in sustainable botanical extracts production. Manages the biorefinery plant in Hervás (Extremadura) and coordinates the SUSTAINEXT project. Responsible for transforming plant by-products (olive leaves, artichoke, thistle, chamomile) into high-value extracts and active ingredients for pharmaceutical, cosmetic, fertilizer, and bioplastic products. NutraResearch transforms these extracts into dietary supplements.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Spanish Association of Food Supplements of which NutraResearch is a member, providing industry representation and networking within the Spanish supplements sector.

Strategic tierCoreTypeOthers
Description

European consortium formed by EU and Bio-based Industries Consortium that funds the SUSTAINEXT project. First project funded by CBE JU, representing €XX million in European support for bio-based industry innovation.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Global supplier of pharmaceutical compounding ingredients, nutraceutical raw materials, and personalized medicine solutions headquartered in the Netherlands. Fagron overlaps directly with NutraResearch's nutraceutical formulation and ingredient selection services.

TypeBroad incumbent
Description

Swiss global CDMO leader, particularly strong in capsules, oral solids, and integrated drug substance/drug product services. Lonza is a megascale incumbent with overlapping nutraceutical and pharma CDMO offerings.

TypeBroad incumbent
Description

Swiss-headquartered global CDMO offering API and finished drug product manufacturing including solid oral dosage forms. Siegfried is a larger Swiss peer operating in the same European CDMO space as NutraResearch.

TypeBroad incumbent
Description

Major US-headquartered global CDMO (now part of Novo Holdings) with extensive oral solid dose and softgel capabilities. Catalent competes for the same large pharmaceutical contract manufacturing RFPs that NutraResearch targets.

TypeBroad incumbent
Description

One of the largest European pharmaceutical CDMOs, headquartered in Germany, with broad capabilities in solid dosage forms and nutraceutical contract manufacturing. Aenova operates at significantly larger scale than NutraResearch but serves overlapping pharmaceutical and supplement customers.

TypeDirect peer
Description

Italian nutraceutical CDMO specializing in development and contract manufacturing of dietary supplements, cosmeceuticals, and functional foods. Roelmi HPC is a direct European peer in the nutraceutical CDMO niche.

TypeDirect peer
Description

Spanish pharmaceutical CDMO headquartered in Pamplona, specializing in small-molecule solid oral dose development and manufacturing for pharma and nutraceutical clients. Idifarma is the closest direct peer to NutraResearch in size, geography, and service mix.

TypeDirect peer
Description

German pharmaceutical company offering CDMO services for solid dosage forms, liquids, and semi-solids. Hermes is a mid-sized European CDMO directly comparable to NutraResearch in scope and pharmaceutical-grade operations.

9Recipharm
TypeBroad incumbent
Description

Swedish-headquartered global pharmaceutical CDMO acquired by EQT. Recipharm is the corporate sibling of NutraResearch's parent Wellma under Nordic ownership and offers directly comparable CDMO services at much larger scale.

TypeBroad incumbent
Description

UK/Northern Ireland-headquartered global pharmaceutical CDMO offering API manufacturing, drug product development, and clinical supply services. Almac competes at higher scale for multinational pharmaceutical CDMO contracts.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

NutraResearch

Contract Pharmaceutical and Nutraceutical Manufacturingnutraresearch.es

NutraResearch is a Barcelona-based pharmaceutical CDMO providing end-to-end R&D, formulation, regulatory, and custom manufacturing services for dietary supplements, medical devices, and nutricosmetics, serving pharmaceutical firms and supplement brands across Europe as part of the Wellma Group.

What NutraResearch does

NutraResearch is a Barcelona-based pharmaceutical Contract Development and Manufacturing Organization (CDMO) that provides end-to-end research, development, and custom manufacturing services for dietary supplements, medical devices, and nutricosmetic products. Founded in 2011 in L'Hospitalet de Llobregat by pharmaceutical industry veterans Carlos Fernández and Carlos Stampa, the company serves pharmaceutical firms, food supplement brands, and cosmetics companies across Europe. Its service portfolio spans the full product lifecycle: active ingredient (API) selection, formulation development, analytical development, industrialization and technology transfer, regulatory dossier preparation, and industrial-scale manufacturing. The company operates a development center and pilot plant at its L'Hospitalet headquarters and a 24/7 three-shift production plant in Barberà del Vallès, the latter acquired in 2021 through the NutraProcés transaction that vertically integrated manufacturing into the platform.

The company's core technology differentiator is its Next-Generation Dietary Supplement Technology Platform, which adapts pharmaceutical-grade controlled-release engineering (including 8+ hour and colon-targeted release profiles) and mucosa bioadhesion chemistry to phytotherapeutic extracts — a class of natural actives whose variability has historically made modified release difficult. In October 2023, NutraResearch also launched the first 100% recyclable blister packaging free of vinyl and aluminum, with moisture barrier performance validated under ICH Q1A stability protocols. The company is a project-based, multi-year B2B enterprise with custom-quoted pricing; revenue is generated through contract R&D services, custom manufacturing (CDMO), and technology transfer. It is part of the Swedish Wellma Group following a January 2025 strategic integration, and participates in the EU-funded SUSTAINEXT consortium (21 companies, 54 months) targeting 40 new active ingredients from sustainable plant cultivation. In April 2025 it became the first food supplement company worldwide to obtain ISO 56001 Innovation Management certification.

NutraResearch firmographics

Firmographics
Name
NutraResearch
Legal name
Nutraresearch 2011, S.L.
Website
https://nutraresearch.es
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
11–50 employees
Short description
NutraResearch is a Barcelona-based pharmaceutical CDMO providing end-to-end R&D, formulation, regulatory, and custom manufacturing services for dietary supplements, medical devices, and nutricosmetics, serving pharmaceutical firms and supplement brands across Europe as part of the Wellma Group.
Ownership category
akta.pro rank

NutraResearch industry classification

Industry
Product category
Contract Pharmaceutical and Nutraceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing (3254)
SIC
Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYHLAGABAB
Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAJ
Packaging, Labeling & Serialization (Clinical/Commercial) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)

Keywords

  • Pharmaceutical contract development
  • Nutraceutical CDMO services
  • Dietary supplement formulation
  • Controlled release technology
  • Custom manufacturing services

Where NutraResearch is headquartered

Location

Headquarters

HQ city
Hospitalet De Llobregat
HQ country
Spain
HQ region
Europe

Offices2 records

Markets served

NutraResearch business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Contract R&D Services: Full-service research and development for pharmaceutical and nutraceutical products, including formulation development, analytical development, and registration dossier preparation. Services range from active substance selection through market-ready product development.
  2. Custom Manufacturing (CDMO): Contract manufacturing of dietary supplements, medical devices, and nutraceutical cosmetics at industrial scale. Following acquisition of Nutraprocés, NutraResearch operates both development pilot plant and production facilities.
  3. Technology Transfer Services: Transfer of manufacturing methods and processes to client facilities, enabling clients to produce products internally after development.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractProject-based pricing for R&D and manufacturing services

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

NutraResearch product offering

Product offering

Core offering

NutraResearch is a Barcelona-based CDMO providing contract R&D, formulation development, analytical services, technology transfer, registration dossier preparation, and industrial-scale custom manufacturing for pharmaceutical and nutraceutical companies. The company applies pharmaceutical-grade technologies — including controlled-release platforms, bioadhesion, and sustainable blister packaging — to develop and manufacture next-generation food supplements, medical devices, and nutraceutical cosmetics.

Product overview

NutraResearch is a leading Barcelona-based CDMO (Contract Development and Manufacturing Organization) specializing in research, development, technology transfer, and custom manufacturing of next-generation food supplements, medical devices, and nutraceutical cosmetics. The company operates as a unified service and product platform offering comprehensive R&D services (API selection, formulation development, analytical development, industrialization, tech transfer, and registration dossiers) alongside a portfolio of 14 dietary supplement product categories covering sports nutrition, skin care, hair care, joint health, weight control, cleansing, anti-stress, veterinary, gynecological, eye care, intestinal health, metabolism regulation, antioxidants, and sleep support. Key technological differentiators include a next-generation controlled-release tablet platform (adapted from pharmaceutical technology), bioadhesion technology for liquid supplements, and the first 100% recyclable sustainable blister packaging. The company, now part of the Swedish Wellma Group following a January 2025 acquisition, serves pharmaceutical and supplement firms across Europe.

Differentiator

Problem solved

Functional benefit

Products and services

  • API Selection Service Expert fitotherapy and botany services for selecting active ingredients that form the basis for product effectiveness, provided to pharmaceutical and nutraceutical client companies.
  • Formulation Development Service Pharmaceutical technology expertise to formulate active ingredients into effective and stable products with optimal release at the point of action, provided to pharmaceutical and supplement companies.
  • Analytical Development Service Partner-provided analytical tools for conducting necessary analytical determinations for new product development, available to pharmaceutical and nutraceutical clients.
  • Industrialization and Tech Transfer Service Comprehensive industrialization services including custom manufacturing through Nutraprocés plant and tech transfer to client facilities for pharmaceutical and supplement brands.
  • Registration Dossier Service Preparation with extensive in-house experience of registration dossiers for new products and modifications of registration dossiers for existing products, serving pharmaceutical and nutraceutical companies.
  • Custom Manufacturing (CDMO) Contract manufacturing of dietary supplements, medical devices, and nutraceutical cosmetics at industrial scale through the production plant in Barberà del Vallès, operating 24/7 in three shifts.
  • Sport Nutrition Supplements Dietary supplements formulated for athletic performance, muscle recovery, and sports-related nutritional support.
  • Skin Care Supplements Nutraceutical products targeting skin health and beauty from within, utilizing advanced formulation technologies.
  • Capillary Care Products Dietary supplements formulated to support hair health, strength, and growth.
  • Osteoarticular Supplements Supplements designed to support joint health, bone strength, and musculoskeletal system function.
  • Weight Control Products Dietary supplements formulated to support weight management and metabolic health.
  • Veterinary Products Nutraceutical formulations designed specifically for animal health applications.
  • Sustainable Blister Packaging First 100% recyclable blister packaging free from vinyl and aluminum, providing moisture protection equivalent to 120-gram PVDC coating, validated through ICH Q1A stability studies.

Quantifiable outcome

  • First food supplement company worldwide to achieve ISO 56001 certification (April 2025)
  • +3 more outcomes

Companies that use NutraResearch

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

NutraResearch technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

NutraResearch partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • WellmacoreStrategic or Co-development Partner · 30 January 2025Strategic partnership joining NutraResearch with Wellma, a leading European nutraceutical and pharmaceutical CDMO with €100M+ in sales. The partnership expands NutraResearch's access to broader product portfolio and greater R&D capabilities, while strengthening Wellma's pan-European presence. NutraResearch operates as part of Wellma's ecosystem while maintaining entrepreneurial culture. Christian Merup is CEO of Wellma.
  • SUSTAINEXT ConsortiumcoreStrategic or Co-development PartnerEuropean consortium project (54 months duration) funded by Circular Bio-based Europe Joint Undertaking (CBE JU), bringing together 21 companies to cultivate medicinal plants for nutraceutical and biofuel applications. NutraResearch serves as expert in phytotherapy and galenic formulation, transforming plant extracts into dietary supplements. Project aims to replace tobacco cultivation in Extremadura with medicinal plants and achieve zero waste/zero emissions. Natac leads and coordinates the project.
  • NataccoreStrategic or Co-development PartnerSpanish company and leader in sustainable botanical extracts production. Manages the biorefinery plant in Hervás (Extremadura) and coordinates the SUSTAINEXT project. Responsible for transforming plant by-products (olive leaves, artichoke, thistle, chamomile) into high-value extracts and active ingredients for pharmaceutical, cosmetic, fertilizer, and bioplastic products. NutraResearch transforms these extracts into dietary supplements.
  • Afepadi (Asociación Española de Complementos Alimenticios)minorStrategic or Co-development PartnerSpanish Association of Food Supplements of which NutraResearch is a member, providing industry representation and networking within the Spanish supplements sector.
  • Circular Bio-based Europe Joint Undertaking (CBE JU)coreOthersEuropean consortium formed by EU and Bio-based Industries Consortium that funds the SUSTAINEXT project. First project funded by CBE JU, representing €XX million in European support for bio-based industry innovation.

Scale indicators8 records

Recent moves7 records

Expansion highlights6 records

NutraResearch competitors and assessment

Company assessment

Direct peers

  • Fagron: Global supplier of pharmaceutical compounding ingredients, nutraceutical raw materials, and personalized medicine solutions headquartered in the Netherlands. Fagron overlaps directly with NutraResearch's nutraceutical formulation and ingredient selection services.
  • Roelmi HPC: Italian nutraceutical CDMO specializing in development and contract manufacturing of dietary supplements, cosmeceuticals, and functional foods. Roelmi HPC is a direct European peer in the nutraceutical CDMO niche.
  • Idifarma: Spanish pharmaceutical CDMO headquartered in Pamplona, specializing in small-molecule solid oral dose development and manufacturing for pharma and nutraceutical clients. Idifarma is the closest direct peer to NutraResearch in size, geography, and service mix.
  • Hermes Arzneimittel: German pharmaceutical company offering CDMO services for solid dosage forms, liquids, and semi-solids. Hermes is a mid-sized European CDMO directly comparable to NutraResearch in scope and pharmaceutical-grade operations.

Broad incumbents

  • Lonza Group: Swiss global CDMO leader, particularly strong in capsules, oral solids, and integrated drug substance/drug product services. Lonza is a megascale incumbent with overlapping nutraceutical and pharma CDMO offerings.
  • Siegfried Holding: Swiss-headquartered global CDMO offering API and finished drug product manufacturing including solid oral dosage forms. Siegfried is a larger Swiss peer operating in the same European CDMO space as NutraResearch.
  • Catalent: Major US-headquartered global CDMO (now part of Novo Holdings) with extensive oral solid dose and softgel capabilities. Catalent competes for the same large pharmaceutical contract manufacturing RFPs that NutraResearch targets.
  • Aenova Group: One of the largest European pharmaceutical CDMOs, headquartered in Germany, with broad capabilities in solid dosage forms and nutraceutical contract manufacturing. Aenova operates at significantly larger scale than NutraResearch but serves overlapping pharmaceutical and supplement customers.
  • Recipharm: Swedish-headquartered global pharmaceutical CDMO acquired by EQT. Recipharm is the corporate sibling of NutraResearch's parent Wellma under Nordic ownership and offers directly comparable CDMO services at much larger scale.
  • Almac Group: UK/Northern Ireland-headquartered global pharmaceutical CDMO offering API manufacturing, drug product development, and clinical supply services. Almac competes at higher scale for multinational pharmaceutical CDMO contracts.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

NutraResearch social profiles

Digital presence

NutraResearch compliance and trust

Trust signal

Compliance1 record

NutraResearch financial estimates

Financial estimate

Revenue estimate

Valuation estimate

NutraResearch leadership team

Management profile

Number of profiles

Profiles7 records

NutraResearch funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

NutraResearch M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NutraResearch

What does NutraResearch do?

NutraResearch is a Barcelona-based CDMO providing contract R&D, formulation development, analytical services, technology transfer, registration dossier preparation, and industrial-scale custom manufacturing for pharmaceutical and nutraceutical companies. The company applies pharmaceutical-grade technologies — including controlled-release platforms, bioadhesion, and sustainable blister packaging — to develop and manufacture next-generation food supplements, medical devices, and nutraceutical cosmetics.

Is NutraResearch a public or private company?

NutraResearch is a private company. It is classified as corporate owned and is currently operating.

When was NutraResearch founded?

NutraResearch was founded in 2011. It employs 11 to 50 people.

Where is NutraResearch based?

NutraResearch is headquartered in Hospitalet De Llobregat, Spain, in the Europe region.

How does NutraResearch make money?

Three revenue lines are on record. Contract R&D Services are the primary driver. The others are custom Manufacturing (CDMO) and technology Transfer Services.

Who are NutraResearch's main competitors?

Direct peers on record are Fagron, Roelmi HPC, Idifarma and Hermes Arzneimittel. Broad incumbents are Lonza Group, Siegfried Holding, Catalent, Aenova Group, Recipharm and Almac Group.

Does NutraResearch have an API?

No public API is recorded for NutraResearch.

What industry is NutraResearch in?

NutraResearch's product category is Contract Pharmaceutical and Nutraceutical Manufacturing. Its primary akta.pro industry code is HLAGABAB, Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO, with a secondary code of HLAGABAJ, Packaging, Labeling & Serialization (Clinical/Commercial) CDMO. Its NAICS code is 3254 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals